Janus Henderson Group
HZNP

Janus Henderson Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Janus Henderson Group’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-134,617
Closed -$15.6M – 2653
2023
Q3 		$15.6M Buy
134,617
+32,517
+32% +$3.49M 0.01% 581
2023
Q2 		$10.5M Sell
102,100
-1,636,046
-94% -$173M 0.01% 684
2023
Q1 		$190M Sell
1,738,146
-2,211,373
-56% -$244M 0.13% 169
2022
Q4 		$449M Sell
3,949,519
-2,087,499
-35% -$173M 0.32% 78
2022
Q3 		$374M Sell
6,037,018
-1,399,592
-19% -$97.8M 0.28% 90
2022
Q2 		$593M Buy
7,436,610
+268,993
+4% +$25.5M 0.41% 51
2022
Q1 		$754M Buy
7,167,617
+115,429
+2% +$11.2M 0.36% 63
2021
Q4 		$760M Buy
7,052,188
+998,456
+16% +$109M 0.32% 72
2021
Q3 		$663M Buy
6,053,732
+229,538
+4% +$23.8M 0.29% 79
2021
Q2 		$545M Sell
5,824,194
-1,772,963
-23% -$163M 0.23% 105
2021
Q1 		$699M Sell
7,597,157
-595,464
-7% -$50.2M 0.32% 77
2020
Q4 		$599M Sell
8,192,621
-745,532
-8% -$55.4M 0.28% 82
2020
Q3 		$694M Buy
8,938,153
+580,629
+7% +$40M 0.36% 60
2020
Q2 		$465M Buy
8,357,524
+1,674,602
+25% +$71.6M 0.26% 87
2020
Q1 		$198M Buy
6,682,922
+807,303
+14% +$27.3M 0.14% 162
2019
Q4 		$213M Buy
+5,875,619
New +$180M 0.11% 209

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Janus Henderson Group's HZNP Position: Q4 2023 in Review

Janus Henderson Group sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 134,617 shares — an estimated $15.6M sold.

Janus Henderson Group first reported a position in HZNP in Q4 2019 and held it in 16 quarters. The position peaked at $760M in Q4 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Janus Henderson Group reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Janus Henderson Group sold 134,617 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $15.6M.
  • Janus Henderson Group first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2019 and held it in 16 quarters.
  • Janus Henderson Group's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $760M in Q4 2021.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Janus Henderson Group's 13F filing for Q4 2023, filed 14 Feb 2024.